HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health And Wellness Launches: C4, CV Sciences, pH-D Feminine, Bucked Up, VitaStix, Shifted

Executive Summary

C4 Relaunch “highlights people getting unstuck”; pH-D line extends with menopause, menstrual and heart supplements; CV Sciences doubles THC in +PlusCBD Reserve Collection Extra; VivaStix Instant Energy + Electrolytes; Bucked Up Pixie Pump pre-workout.

You may also be interested in...



Bucked Up Bucks Brand Sponsorship Trends: Rodeo Champions, Bare Knuckle Fighting, Ball Hockey

Firm also recently became official energy drink partner of Bare Knuckle Fighting Championship and an official sponsor of National Ball Hockey League for 2023 season and of Jimmy Johnson’s “Quest for the Ring” Championship Fishweek in Florida.

Vagisil Marketer Combe Enters Personal Lubricant Market With BioFilm Acquisition

Vagisil and BioFilm’s Astroglide “demonstrate very high levels of brand awareness, brand loyalty, and repeat purchase, and continue to attract new and younger consumers into the category,” firms say.

US Health And Wellness Launches: Perrigo, Lightbody, Nature’s Bounty, PLT, Healthycell, More

Nicotine mint lozenge approval for Perrigo; Lightbody for digital vision health; PLT has broad-spectrum immune health ingredient; Souvenaid for stronger synapses; Kinesiology tape for cellular oxygenation; Healthycell joint health and mobility gel; Nature’s Bounty Optimal Solutions hair, metabolism supplements; and Perricone extends vitamin c ester line.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153595

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel